Jan. 22, 2024

WRAIR scientists and collaborators identify previously unreported animal reservoirs for Lassa virus in Nigeria

In collaboration with the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Walter Reed Army Institute of Research (WRAIR) completed a study demonstrating, for the first time, that non-rodents such as lizards, pigs, dogs, sheep, goats and cattle are reservoirs for Lassa virus (LASV) in southern Nigeria. These non-rodent

Sept. 13, 2022

Malaria vaccine candidate safe and immunogenic following first-in-human trials

Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the first-in-human evaluation results published in the Vaccine journal. Although malaria control efforts yielded steady progress over the past decade, instability

Jan. 27, 2022

Zika vaccine shows promising results in preclinical studies

A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies, according to a new study in the journal npj Vaccines.The research is a collaboration between Trudeau Institute, Texas Biomedical Research Institute’s Southwest National Primate Research Center (SNPRC), and Walter Reed

Dec. 16, 2021

Series of preclinical studies supports the Army’s pan-coronavirus vaccine development strategy

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research (WRAIR) not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other

Oct. 19, 2021

New malaria vaccine candidate enters test phase

The World Health Organization recommended the first vaccine for malaria on October 6 for sub-Saharan African and other areas with moderate to high transmission rates, bringing hope to parts of the world where it kills more than 400,000 people a year. That doesn’t mean the search for even better vaccines is over. For more than three decades, the

Aug. 31, 2021

Koenig assumes command of WRAIR

Col. Chad Koenig assumed responsibility as the 48th commander of the Walter Reed Army Institute of Research during an assumption of command ceremony here at the Sen. Daniel Inouye Building Aug. 31.Koenig replaces Brig. Gen. Clint Murray who relinquished responsibility of WRAIR July 8 after his nomination to brigadier general was approved by the

July 16, 2021

VectorMap returns with major upgrades

Predicting the next vector-borne disease outbreak such as West Nile or Lyme disease, just became easier today. That is because VectorMap, the world’s largest database of expertly curated, arthropod vector collection data has returned to the public domain, for the first time in more than two years.VectorMap provides researchers, public health

July 8, 2021

Murray relinquishes command of WRAIR

Col. Clint Murray relinquished command of Walter Reed Army Institute of Research in a brief ceremony today here in Silver Spring, Md.Murray gave up the command more than a year before he was originally planned to, as his nomination to brigadier general was confirmed by the U.S. Senate on June 24. Col. Robert O’Connell, WRAIR’s deputy commander,

June 20, 2021

mRNA Vaccine Yields Full Protection against Malaria in Mice

Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology that protects against malaria in animal models, publishing their findings in npj Vaccines.In 2019, there were an

May 4, 2021

Chronic Exposure to Low Levels of Blast May Be Associated with Neurotrauma

Scientists at the Walter Reed Army Institute for Research demonstrated that biomarkers associated with traumatic brain injury were elevated among law enforcement and military personnel, particularly in active duty participants with longer duration of service. Most notably, these elevated biomarker levels were observed in individuals without a